Atlas Trials

Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer

Clinical trial NCT04081389 · COMPLETED

Trial details

NCT number
NCT04081389
Sponsor
Roswell Park Cancer Institute
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Early-Stage Breast CarcinomaEstrogen Receptor NegativeHER2/Neu NegativeProgesterone Receptor NegativePrognostic Stage 0 Breast Cancer AJCC v8
Start date
2019-12-06
Primary completion
2022-05-24
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.